Login
+44 203 371 1100
Login
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 13-Dec-2018 | New Bond | - | - | US584688AJ43 |
| Medicines Company/The has issued USD 172500M, 3.50% fixed rate bond due 15-Jan-2024. | ||||
| 08-Jan-2018 | Asset Sale | - | - | US00214WAE12 |
| Medicines Company/The announced today that it has sold its infectious disease business unit to Melinta Subsidiary Corp. | ||||
| 29-Nov-2017 | Propose Asset Sale | - | - | US00214WAE12 |
| Medicines Company/The announced today that it has signed an agreement to sell its infectious disease business to Melinta Subsidiary Corp. | ||||
| 31-Aug-2015 | Purchase Stock | Target Name | Eshelman Ventures, LLC | US00214WAE12 |
| Eshelman Ventures, LLC today announced that it has acquired 944,537 shares of common stock of Medicines Company/The. | ||||
| 18-Dec-2015 | Propose Asset Sale | - | - | US00214WAE12 |
| Medicines Company/The today announced that it has agreed to sell its Hemostasis Portfolio to Mallinckrodt plc. | ||||
All of the financial data available on this page is sourced from FactEntry.